Odendall Charlotte, Voak Andrew A, Kagan Jonathan C
Harvard Medical School, Boston, MA 02115;
Division of Gastroenterology, Boston Children's Hospital, Boston, MA 02115; and.
J Immunol. 2017 Nov 1;199(9):3270-3279. doi: 10.4049/jimmunol.1700250. Epub 2017 Sep 27.
Type III IFNs (IFN-λs) are secreted factors that are well-known for their antiviral activities. However, their regulation and functions during bacterial infections are unclear. In this article, we report that the regulation of IFN-λ genes did not track with mechanisms that control type I IFN expression in response to TLRs. Whereas type I IFNs were only expressed from TLRs present on endosomes, type III IFNs could be induced by TLRs that reside at the plasma membrane and that detect various bacterial products. The mechanisms that regulate type III IFN gene expression tracked with those that promote inflammatory cytokine and chemokine expression. Importantly, rIFN-λs enhanced epithelial barriers in vitro, preventing transcellular bacteria dissemination. We therefore propose that in addition to their functions in cell-intrinsic antiviral immunity, type III IFNs protect epithelial barrier integrity, an activity that would benefit the host during any infectious encounter.
III型干扰素(IFN-λs)是一种分泌因子,以其抗病毒活性而闻名。然而,它们在细菌感染过程中的调控和功能尚不清楚。在本文中,我们报道IFN-λ基因的调控并不遵循控制I型干扰素表达以响应Toll样受体(TLRs)的机制。I型干扰素仅从内体上存在的TLRs表达,而III型干扰素可由位于质膜上并检测各种细菌产物的TLRs诱导。调节III型干扰素基因表达的机制与促进炎性细胞因子和趋化因子表达的机制一致。重要的是,重组IFN-λs在体外增强了上皮屏障,防止细菌跨细胞扩散。因此,我们提出,除了在细胞内抗病毒免疫中的功能外,III型干扰素还能保护上皮屏障的完整性,这一活性在任何感染过程中都将使宿主受益。